Glucan particles for macrophage targeted delivery of nanoparticles.
about
Recent advances in oral vaccine development: yeast-derived β-glucan particlesTurning 21: Induction of miR-21 as a Key Switch in the Inflammatory ResponseMRI tracking of macrophages labeled with glucan particles entrapping a water insoluble paramagnetic Gd-based agent.Allele-Selective Suppression of Mutant Huntingtin in Primary Human Blood Cells.Preparation and characterization of beta-glucan particles containing a payload of nanoembedded rifabutin for enhanced targeted delivery to macrophages.Exploiting fungal cell wall components in vaccinesA population of Langerin-positive dendritic cells in murine Peyer's patches involved in sampling β-glucan microparticles.Protection against Experimental Cryptococcosis following Vaccination with Glucan Particles Containing Cryptococcus Alkaline Extracts.Targeted Delivery of Glucan Particle Encapsulated Gallium Nanoparticles Inhibits HIV Growth in Human Macrophages.Immunostimulatory properties and antitumor activities of glucans (Review).Duality of β-glucan microparticles: antigen carrier and immunostimulants.Caspase-8 modulates dectin-1 and complement receptor 3-driven IL-1β production in response to β-glucans and the fungal pathogen, Candida albicans.Vaccination with Recombinant Cryptococcus Proteins in Glucan Particles Protects Mice against Cryptococcosis in a Manner Dependent upon Mouse Strain and Cryptococcal Species.Nitric oxide-activatable gold nanoparticles for specific targeting and photo-thermal ablation of macrophages.Beta-Glucan Particles as Vaccine Adjuvant Carriers.Optimizing Tumor Microenvironment for Cancer Immunotherapy: β-Glucan-Based Nanoparticles.Glucan particles loaded with a NIRF agent for imaging monocytes/macrophages recruitment in a mouse model of rheumatoid arthritis
P2860
Q27001699-0B936E82-F76F-4B7D-859B-C48110628AF6Q28083164-2C3CB2DF-1040-4F4A-8CA8-32E610418537Q30578470-41EE89C9-E90F-4505-845B-8436570B95A5Q33594270-5A9A1E1D-A7FD-422E-A754-B38C823FA2A7Q33667215-3057EA6A-C842-4E68-AE83-8919CA92A23FQ35085200-FD1D918F-FCA1-4571-837E-CC36BEF781D0Q35121693-8513BF53-AC11-41FB-B9C4-0508966B5437Q36431583-7DEF60B4-A559-45E1-998E-D394669F552AQ37443661-52366BE6-D9E8-4730-A2C2-91FBA877FEFBQ38112321-EDBE1B5B-F0D1-4DCF-8D51-6E5F814C2CC8Q40688473-20E5CD25-748E-4023-A27A-9D46DB6B11EBQ42088304-099C9130-3440-4C05-A8D3-2E9F2C7FA299Q46252449-EE07DCB7-5237-454E-993F-AA3BBBA55F6DQ49684303-683A1163-ED41-4AF4-9219-F9AE86CEB3BAQ50957928-01BDD457-D05F-41C7-AE09-DAE15C094389Q52657150-B0530F40-0E36-479A-8604-F8854A0341D8Q58830266-415D4CB7-E4DD-4513-9255-27B467802053
P2860
Glucan particles for macrophage targeted delivery of nanoparticles.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Glucan particles for macrophage targeted delivery of nanoparticles.
@en
type
label
Glucan particles for macrophage targeted delivery of nanoparticles.
@en
prefLabel
Glucan particles for macrophage targeted delivery of nanoparticles.
@en
P2093
P2860
P356
P1476
Glucan particles for macrophage targeted delivery of nanoparticles.
@en
P2093
Abaigeal C Caras
Ernesto R Soto
Gary R Ostroff
Lindsey C Kut
Melissa K Castle
P2860
P304
P356
10.1155/2012/143524
P577
2011-10-13T00:00:00Z